Novo Nordisk’s GLP-1 drug Semaglutide, sold under brand names Ozempic and Wegovy, has been hailed as a miracle drug for ...

Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.' ...

Telehealth company Hims & Hers Health (HIMS) witnessed a major dip in its stock recently despite reporting 95% revenue growth ...

Novo Nordisk warns of potential price hikes and shortages amid global tariff threats, impacting drug prices and supply chains ...

The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents.

The plans for reforming SNAP represent nanny-ism on steroids. The proposals will fatten the pockets of lobbyists and federal ...

Both studies estimated that India’s number of overweight and obese people will keep increasing till 2050. What may be the ...